NOVARTIS A G's ticker is NVS and the CUSIP is 66987V109. A total of 1,160 filers reported holding NOVARTIS A G in Q1 2023. The put-call ratio across all filers is 0.47 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $1,398,317 | +0.9% | 13,728 | 0.0% | 0.62% | +4.5% |
Q2 2023 | $1,385,275 | +8.1% | 13,728 | -1.4% | 0.60% | +3.7% |
Q1 2023 | $1,281,360 | +101033.4% | 13,928 | -0.3% | 0.57% | -4.0% |
Q4 2022 | $1,267 | -99.9% | 13,970 | -0.7% | 0.60% | +10.5% |
Q3 2022 | $1,069,000 | -10.8% | 14,070 | -0.7% | 0.54% | -5.7% |
Q2 2022 | $1,198,000 | -3.6% | 14,170 | 0.0% | 0.57% | +12.3% |
Q1 2022 | $1,243,000 | -1.7% | 14,170 | -1.9% | 0.51% | +3.9% |
Q4 2021 | $1,264,000 | +8.5% | 14,446 | +1.4% | 0.49% | -6.5% |
Q3 2021 | $1,165,000 | -10.4% | 14,246 | 0.0% | 0.53% | -9.8% |
Q2 2021 | $1,300,000 | +6.7% | 14,246 | 0.0% | 0.58% | -2.2% |
Q1 2021 | $1,218,000 | -9.4% | 14,246 | +0.0% | 0.60% | -15.3% |
Q4 2020 | $1,345,000 | +8.6% | 14,239 | 0.0% | 0.70% | -5.0% |
Q3 2020 | $1,238,000 | -0.8% | 14,239 | -0.3% | 0.74% | -8.4% |
Q2 2020 | $1,248,000 | +5.9% | 14,289 | 0.0% | 0.81% | -11.6% |
Q1 2020 | $1,178,000 | -13.3% | 14,289 | -0.5% | 0.92% | +4.1% |
Q4 2019 | $1,359,000 | +7.4% | 14,357 | -1.4% | 0.88% | +0.9% |
Q3 2019 | $1,265,000 | -6.3% | 14,557 | -1.5% | 0.87% | -6.4% |
Q2 2019 | $1,350,000 | -5.0% | 14,782 | 0.0% | 0.93% | -4.5% |
Q1 2019 | $1,421,000 | +11.3% | 14,782 | -0.6% | 0.98% | -1.1% |
Q4 2018 | $1,277,000 | -1.7% | 14,877 | -1.3% | 0.99% | +17.9% |
Q3 2018 | $1,299,000 | +13.4% | 15,077 | -0.7% | 0.84% | +3.0% |
Q2 2018 | $1,146,000 | -6.3% | 15,177 | +0.4% | 0.81% | -8.6% |
Q1 2018 | $1,223,000 | -4.0% | 15,123 | -0.3% | 0.89% | -7.3% |
Q4 2017 | $1,274,000 | -2.5% | 15,173 | -0.3% | 0.96% | -10.6% |
Q3 2017 | $1,307,000 | +2.8% | 15,223 | 0.0% | 1.07% | +0.2% |
Q2 2017 | $1,271,000 | +12.1% | 15,223 | -0.3% | 1.07% | +11.8% |
Q1 2017 | $1,134,000 | +2.0% | 15,265 | 0.0% | 0.96% | -3.8% |
Q4 2016 | $1,112,000 | -7.7% | 15,265 | 0.0% | 0.99% | -7.8% |
Q3 2016 | $1,205,000 | -4.4% | 15,265 | 0.0% | 1.08% | -6.7% |
Q2 2016 | $1,260,000 | -53.3% | 15,265 | -51.6% | 1.16% | -2.8% |
Q1 2016 | $2,699,000 | +99.8% | 31,511 | +100.6% | 1.19% | -3.5% |
Q4 2015 | $1,351,000 | -7.0% | 15,708 | -0.6% | 1.23% | -7.7% |
Q3 2015 | $1,453,000 | -6.6% | 15,808 | 0.0% | 1.34% | -1.1% |
Q2 2015 | $1,555,000 | -0.8% | 15,808 | -0.6% | 1.35% | +0.6% |
Q1 2015 | $1,568,000 | +6.5% | 15,903 | +0.1% | 1.34% | +2.3% |
Q4 2014 | $1,472,000 | – | 15,885 | – | 1.31% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
GODSEY & GIBB, INC | 184,900 | $15,121,000 | 6.74% |
Martin Investment Management, LLC | 289,924 | $23,710,000 | 5.98% |
Camber Capital Management LP | 2,000,000 | $163,560,000 | 5.04% |
MANAGED ASSET PORTFOLIOS, LLC | 381,778 | $31,222,000 | 4.76% |
PROFESSIONAL ADVISORY SERVICES INC | 267,779 | $21,899,000 | 3.22% |
SCHARF INVESTMENTS, LLC | 1,244,711 | $101,794,000 | 3.21% |
GARLAND CAPITAL MANAGEMENT INC | 50,755 | $4,151,000 | 2.97% |
First Fiduciary Investment Counsel, Inc. | 167,378 | $13,688,000 | 2.67% |
WILKINS INVESTMENT COUNSEL INC | 130,590 | $10,680,000 | 2.61% |
Lowell Blake & Associates Inc. | 66,309 | $5,423,000 | 2.52% |